New coronavirus: What you need to know
A new flu-like strain of the coronavirus has been reported in China, South Korea, Taiwan, Japan, Thailand and the US.
Jan 24, 2020
0
1
A new flu-like strain of the coronavirus has been reported in China, South Korea, Taiwan, Japan, Thailand and the US.
Jan 24, 2020
0
1
An in-depth analysis of strict travel bans, both within and outside of China, finds that they may have done little to impede the spread of coronavirus.
Mar 9, 2020
0
143
The United States said Friday it is seriously considering creating a vaccine passport for Americans traveling abroad.
May 28, 2021
0
2
Iran may have significantly more cases of Coronavirus Disease 2019 (COVID-19) than the 43 that were reported to the public. A brief report published in Annals of Internal Medicine suggests that Iran would need to have approximately ...
Mar 17, 2020
0
1
The ground-zero city of Wuhan is cautiously reopening after a two-month quarantine, but the birthplace of the global coronavirus pandemic is now on guard against a potential new threat: imported cases.
Mar 29, 2020
0
10
The Chinese government has quarantined Wuhan, a port city of 11 million people, and it has restricted travel to and from several other cities, including Beijing, to contain the coronavirus that has sickened more than 800 ...
Jan 27, 2020
0
3
People who are more active when commuting to work by walking or cycling could be cutting their relative risk of developing ischaemic heart disease or stroke by 11% and their relative risk of dying from these diseases by 30%, ...
May 21, 2018
0
123
Federal health officials on Monday classified a dozen countries as having "very high" COVID-19 risk, warning U.S. travelers to avoid the destinations regardless of vaccination status.
Feb 2, 2022
0
11
France and Russia prepared to beef up their coronavirus inoculation programmes from next week, even as authorities on Sunday sought to allay concerns about supplies of the vaccines while the global pandemic shows no sign ...
Jan 17, 2021
0
4
China on Saturday said it had given "conditional" approval for Pfizer's COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
Feb 12, 2022
0
8